Dr Daniel Utzschneider from Peter Doherty is doing amazing
#research
with the support of a
#CSLCentenaryFellowship
. Applications for 2025 are now open:
Applications are open for the 2025 CSL Centenary Fellowships. Australian early-mid career biomedical
#researchers
are invited to apply for 1 of 2 A$1.25m
#grants
over 5 years.
Australia’s newest biotech incubator has officially opened.
@Jumarbio
is a world-class hub for biotech innovation translation, research commercialisation & talent development that will help to progress discoveries towards real-world patient treatments.
Looking ahead to Earth Day later this month, CSL's Chief Sustainability Officer Jeffrey Ball shared an update about our environmental sustainability progress so far. Read more:
#CSL
#Sustainability
#EarthDay
Our
#WFH2024
symposium will explore ways to optimize the route to diagnosis and treatment in
#VWD
, on Tuesday 23 April 12:45–13:45 CET. Join us at the IFEMA Convention Centre in Madrid, Spain and register for
#WFHCongress
here
It’s
#RareDiseaseDay
and CSL has joined the Global Chain of Lights in Bern, Switzerland! All day, teams of green-minded people rode stationary bicycles to generate the energy needed to
#LightUpforRare
at Burgerspital Bern.
Tomorrow at
#AAAAI24
, we’re hosting an interactive symposium from our esteemed faculty on a mysterious disease state. Uncover the secret and solve the patient puzzle, while learning about how to optimize patient care from diagnosis to disease management.
#DrivenByOurPromise
Join our live Meet the Experts series at
#AAAAI24
for perspectives on primary immunodeficiency. Hear from a patient advocate on their experience with diagnosis and treatment, and experts Dr. Heimall and Dr. Mustafa on managing complex
#PID
cases.
#DrivenByOurPromise
We’re attending the
@AAAAI_org
Annual Meeting in Washington, DC from February 23-26! Come to our Meet the Experts series on diagnosing and treating
#PID
at our booth
#325
and tune in to our interactive symposium on optimizing the patient experience.
#AAAAI24
#DrivenByOurPromise
CEO and Managing Director Paul McKenzie speaks to the outlook for CSL. A recording of our half year earnings webcast can be found at our investor center:
CSL’s Head of Research & Development, Dr. Bill Mezzanotte, weighs in on how the AEGIS-II program has left a lasting impact on our organization. Read more:
This week marks Women’s Heart Week, a time to support education, prevention and early intervention around
#HeartHealth
, not just for women, but for all individuals.
Dr. Duffy reflects on the importance of conversations around women’s heart health and CSL’s commitment to CVD.
February is American
#HeartMonth
, and CSL is determined to do our part in the fight against
#HeartDisease
. We strive to pave the way for a better future for CV patients worldwide through our
#cardiovascular
and metabolic research program.
A beautiful summer morning dawns with the sun shining on CSL’s Global Headquarters and Centre for R&D, which stands proudly as a landmark on the Melbourne skyline, and in the heart of the biomedical district.
📷: walking_perspective/Instagram
#CSL
#Melbourne
#Summer